NCT00000239
- Conditions
- Chemically-Induced Disorders, Mental Disorders, Narcotic-Related Disorders, +3 more
- Locations
-
- Treatment Research Center Burlington, Vermont, United States
Clinical trial condition
Opioid-Related Disorders
Explore clinical trials studying Opioid-Related Disorders. Study availability and eligibility vary by location and protocol.
1,202 public trials
194 recruiting studies
Opioid-Related Disorders trial results
NCT00000228
- Conditions
- Chemically-Induced Disorders, Mental Disorders, Narcotic-Related Disorders, +3 more
- Locations
-
- Treatment Research Center Burlington, Vermont, United States
NCT00000225
- Conditions
- Chemically-Induced Disorders, Mental Disorders, Narcotic-Related Disorders, +3 more
- Locations
-
- Treatment Research Center Burlington, Vermont, United States
NCT00000223
- Conditions
- Chemically-Induced Disorders, Mental Disorders, Narcotic-Related Disorders, +3 more
- Locations
-
- Treatment Research Center Burlington, Vermont, United States
NCT00000221
- Conditions
- Chemically-Induced Disorders, Mental Disorders, Narcotic-Related Disorders, +3 more
- Locations
-
- Treatment Research Center Burlington, Vermont, United States
Completed
Alternate-Day Buprenorphine. Phase V - 6
NCT00000224
- Conditions
- Chemically-Induced Disorders, Mental Disorders, Narcotic-Related Disorders, +3 more
- Locations
-
- Treatment Research Center Burlington, Vermont, United States
NCT00000222
- Conditions
- Chemically-Induced Disorders, Mental Disorders, Narcotic-Related Disorders, +3 more
- Locations
-
- Treatment Research Center Burlington, Vermont, United States
NCT00000226
- Conditions
- Chemically-Induced Disorders, Mental Disorders, Narcotic-Related Disorders, +3 more
- Locations
-
- Treatment Research Center Burlington, Vermont, United States
NCT00000220
- Conditions
- Chemically-Induced Disorders, Mental Disorders, Narcotic-Related Disorders, +3 more
- Locations
-
- Treatment Research Center Burlington, Vermont, United States
Active, Not Recruiting
Kentucky Outreach Service Kiosk (KyOSK): Reducing HIV, HCV, and Overdose Risk
NCT05657106
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Chemically-Induced Disorders, +36 more
- Locations
-
- University of Kentucky Lexington, Kentucky, United States